Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety in Healthcare Professionals of the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac
Latest Information Update: 20 Feb 2024
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Acronyms PROFISCOV
Most Recent Events
- 14 Feb 2024 Status changed from active, no longer recruiting to completed.
- 10 Feb 2021 Planned End Date changed from 1 Oct 2021 to 1 Feb 2022.
- 10 Feb 2021 Status changed from recruiting to active, no longer recruiting.